CompletedNCT03348384
[11C]NOP-1A and Cocaine Use Disorders
Medication studyAges 18–50United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: October 30, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 49
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, RADIATION
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT03348384
- Official title
Show the full official title
Linking Nociceptive Opioid Peptide (NOP) Receptors With Relapse in Cocaine Use Disorders
Get this study by email
Recruitment & locations
CompletedPittsburgh
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including NOP-1A.
Who was this study for?
Listed age limits: 18 years to 50 years.
Want to explore more studies?
Explore studiesRelated studies
[C-11]NOP-1A and Addiction
[C-11]PiB PET Imaging in Alcohol Use Disorders